3190 results for «835»

Filter By

3190 results

Real world outcomes and strategies for optimal TEER across diverse DMR anatomies

14 Feb 2026 – From PCR Tokyo Valves 2026

This session develops a nuanced understanding of the complexity inherent in DMR cases, informed by the latest registry data. It highlights the capabilities of the PASCAL device in managing challenging anatomies and achieving predictable clinical results, alongside contemporary strategies for device selection and optimal placement to...

Real world outcomes and strategies for optimal TEER across diverse DMR anatomies

TAVI today and tomorrow: international trends and future direction

14 Feb 2026 – From PCR Tokyo Valves 2026

This session focuses on the evolving landscape of TAVI, emphasising lifetime management strategies with a focus on the first valve implanted. It provides a comprehensive discussion on representative patient profiles, current guidelines from various countries, and future outlooks, alongside recent long-term clinical results for the balloon-expandable...

TAVI today and tomorrow: international trends and future direction

Built to last: lifetime management for durability and beyond

14 Feb 2026 – From PCR Tokyo Valves 2026

This session addresses the principles of lifetime management aimed at durability and optimal long-term outcomes in complex valvular heart disease cases. Key topics include the critical importance of initial valve choice, practical tips for optimizing paravalvular leak (PVL) management, and advanced strategies for redo transcatheter aortic...

Built to last: lifetime management for durability and beyond

Protect the brain for TAVI - True potential of SENTINEL Cerebral Protection System

14 Feb 2026 – From PCR Tokyo Valves 2026

This session highlights the critical role of cerebral protection during TAVI procedures by focusing on the SENTINEL Cerebral Protection System. It reviews trends in the United States and Japan, presents clinical outcomes one year post-introduction in Japan, and examines key clinical trials through a meta-analysis comparing...

Protect the brain for TAVI - True potential of SENTINEL Cerebral Protection System

New horizons in structural heart disease therapy - Cutting-edge stroke prevention devices: WATCHMAN × SENTINEL

15 Feb 2026 – From PCR Tokyo Valves 2026

This session delves into the advances in stroke prevention for patients undergoing TAVI with atrial fibrillation, focusing on left atrial appendage closure (LAAC) and cerebral protection strategies. It highlights the evolving role of WATCHMAN devices and the SENTINEL Cerebral Protection System, emphasising perioperative stroke risk management...

New horizons in structural heart disease therapy - Cutting-edge stroke prevention devices: WATCHMAN × SENTINEL

Mastering mitral TEER: guidelines, complex cases, and Asia Pacific insights

14 Feb 2026 – From PCR Tokyo Valves 2026

Focused on mastering mitral transcatheter edge-to-edge repair (TEER), this session analyzed the 2025 ESC VHD guidelines and their clinical implications. It addressed optimal timing and treatment strategies for severe heart failure beyond the COAPT trial and explored technical solutions for complex anatomies, including customization approaches for...

Mastering mitral TEER: guidelines, complex cases, and Asia Pacific insights

Restriction in supra-annular transcatheter heart valve leaflet mobility during coronary access after valve-in-valve TAVI

05 Apr 2022

This Image in Interventional Cardiology highlights how patient-specific ex vivo simulations offer physicians the opportunity to observe and evaluate the potential in vivo impact of different techniques particularly for complex structural heart interventions.

Restriction in supra-annular transcatheter heart valve leaflet mobility during coronary access after valve-in-valve TAVI

Frequency and safety of bioprosthetic valve fracture in patients undergoing valve in valve TAVR for failed surgical valves using the SAPIEN 3/Ultra Valves: Insights from real-world data

19 Sep 2022

Michele Pighi provides his take on this trial which aimed to compare the safety and efficacy of VIV-TAVI with or without bioprosthetic valve fracture. It was presented by Santiago Garcia during the TCT Congress 2022.

M. Pighi

Author

Michele Pighi
Bioprosthetic valve fracture in ViV-TAVR

Landmark results from S-FLEX UK-II registry published in BMJ Open: Supraflex Cruz demonstrates outstanding performance

03 Dec 2024

Implantation of the Portico With FlexNav TAVI System in a patient with aortic stenosis, severe renal impairment, and diffuse iliac atherosclerosis

12 May 2020

Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.

Implantation of the Portico With FlexNav TAVI System in a patient with aortic stenosis, severe renal impairment, and diffuse iliac atherosclerosis
Didn’t find what you were looking for?